ADLS Insider Trading Activity and SEC Form 4 Filings
ADLS insider trading summary
No open-market insider purchases or sales of Advanced Life Sciences Holdings, Inc. (ADLS) have been reported on SEC Form 4 in the past 12 months.
Latest ADLS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 7, 2010 | Richard A Reck | Director | Buy | $50K (1,190,000 @ $0.04) |
| Dec 10, 2008 | Richard A Reck | Director | Buy | $18K (50,000 @ $0.35) |
| Mar 31, 2008 | Richard A Reck | Director | Buy | $18K (20,000 @ $0.89) |
| Feb 28, 2008 | Michael T Flavin | Chief Executive Officer | Buy | $9K (10,000 @ $0.91) |
| Feb 28, 2008 | Rosalie Sagraves | Director | Buy | $2K (2,100 @ $0.94) |
| Feb 28, 2008 | Rosalie Sagraves | Director | Buy | $288 (300 @ $0.96) |
| Feb 28, 2008 | Rosalie Sagraves | Director | Buy | $95 (100 @ $0.95) |
| Feb 27, 2008 | John L Flavin | President | Buy | $1K (1,200 @ $0.91) |
| Feb 27, 2008 | Ze Qi Xu | EVP and CSO | Buy | $906 (1,000 @ $0.91) |
| Feb 27, 2008 | Michael T Flavin | Chief Executive Officer | Buy | $1K (1,500 @ $0.91) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.